In this podcast, EMJ are joined by Henrik Grönberg, Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Solna, Sweden. Focusing on the topic of precision medicine in prostate cancer, this podcast offers valuable insights into the impact that its widespread implementation could have for patients.
This podcast is supported by Janssen Pharmaceutical Companies of Johnson & Johnson. The views expressed in this podcast are those of the individual speaker and do not necessarily reflect the views of Janssen Pharmaceutical Companies of Johnson & Johnson.
CP-356569, November 2022